SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3x1l'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FDU_D_ESTD352_1
(17-BETA-HYDROXYSTERO
ID DEHYDROGENASE)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		4 / 6 SER H 223
VAL H 224
GLY H 225
GLU H 206
 None
 0.47A 1fduD-3x1lH:
undetectable		 1fduD-3x1lH:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHY_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 9 GLY A 856
PHE A 860
LEU A 857
SER A 761
ARG A 846
 None
 1.32A 1jhyA-3x1lA:
undetectable		 1jhyA-3x1lA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX8_A_RTLA135_0
(CELLULAR
RETINOL-BINDING
PROTEIN I, HOLO)		 3x1l CMR4
CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus;
Archaeoglobus
fulgidus) 		5 / 12 LEU F  98
ALA F 136
LEU F 137
PHE C 254
ILE F 131
 None
 1.03A 1mx8A-3x1lF:
undetectable		 1mx8A-3x1lF:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NP1_A_HSMA303_1
(NITROPHORIN 1)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 5 GLU A 332
LEU A 326
LEU A 329
LEU A 327
 None
 1.15A 1np1A-3x1lA:
undetectable		 1np1A-3x1lA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OIP_A_VIVA1278_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 ILE A 226
ILE A 224
LEU A 222
VAL A 306
ILE A 314
 None
 0.86A 1oipA-3x1lA:
undetectable		 1oipA-3x1lA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_C_BEZC505_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 6 ILE A 289
PRO A 278
GLU A 292
ARG A 655
 None
 1.30A 1oniA-3x1lA:
undetectable
1oniC-3x1lA:
undetectable		 1oniA-3x1lA:
13.58
1oniC-3x1lA:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_G_BEZG513_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 5 ARG A 655
ILE A 289
PRO A 278
GLU A 292
 None
 1.30A 1oniG-3x1lA:
undetectable
1oniH-3x1lA:
undetectable		 1oniG-3x1lA:
13.58
1oniH-3x1lA:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PXX_C_DIFC2701_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 VAL A 763
LEU A 762
SER A 761
LEU A 734
GLY A 713
 None
 1.09A 1pxxC-3x1lA:
1.5		 1pxxC-3x1lA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RB3_B_MTXB161_1
(DIHYDROFOLATE
REDUCTASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 ILE A 270
ALA A 302
LEU A 424
LEU A 375
ILE A 305
 None
 1.00A 1rb3B-3x1lA:
undetectable		 1rb3B-3x1lA:
13.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 11 ALA A 712
ILE A 749
GLY A 750
ILE A 596
VAL A 687
 None
 0.93A 1sduA-3x1lA:
undetectable		 1sduA-3x1lA:
9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X8V_A_ESLA471_1
(CYTOCHROME P450 51)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 8 PHE A 279
ARG A 658
ALA A 670
MET A 251
 None
 1.19A 1x8vA-3x1lA:
undetectable		 1x8vA-3x1lA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA4_A_CTXA1_1
(CES1 PROTEIN)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 12 ALA H 320
PHE H 148
GLY H 141
LEU H 317
LEU H 316
 None
None
U  I  26 ( 3.2A)
None
None
 0.93A 1ya4A-3x1lH:
undetectable		 1ya4A-3x1lH:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z9H_A_IMNA379_1
(MEMBRANE-ASSOCIATED
PROSTAGLANDIN E
SYNTHASE-2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 PRO A 266
PRO A 278
VAL A 643
SER A 646
VAL A 269
 None
 1.41A 1z9hA-3x1lA:
undetectable		 1z9hA-3x1lA:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z9H_B_IMNB381_1
(MEMBRANE-ASSOCIATED
PROSTAGLANDIN E
SYNTHASE-2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 PRO A 266
PRO A 278
VAL A 643
SER A 646
VAL A 269
 None
 1.42A 1z9hB-3x1lA:
undetectable		 1z9hB-3x1lA:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z9H_C_IMNC379_1
(MEMBRANE-ASSOCIATED
PROSTAGLANDIN E
SYNTHASE-2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 PRO A 266
PRO A 278
VAL A 643
SER A 646
VAL A 269
 None
 1.42A 1z9hC-3x1lA:
undetectable		 1z9hC-3x1lA:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2I2Z_A_SALA1100_1
(SERUM ALBUMIN)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 5 LEU C  54
LEU C  13
ILE C 330
ILE C  45
 None
 0.76A 2i2zA-3x1lC:
undetectable		 2i2zA-3x1lC:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PO7_A_CHDA501_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 12 LEU H 260
LEU H  54
SER H 117
PRO H  41
TRP H  23
 None
 1.09A 2po7A-3x1lH:
undetectable		 2po7A-3x1lH:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PO7_B_CHDB501_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 12 LEU H 260
LEU H  54
SER H 117
PRO H  41
TRP H  23
 None
 1.10A 2po7B-3x1lH:
undetectable		 2po7B-3x1lH:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBN_A_CAMA442_0
(CYTOCHROME P450-CAM)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 7 PHE C  11
VAL C 318
VAL C 123
VAL C 297
 None
 0.90A 2qbnA-3x1lC:
undetectable		 2qbnA-3x1lC:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBO_A_CAMA442_0
(CYTOCHROME P450-CAM)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		5 / 10 PHE C  11
THR C 322
VAL C 123
ILE C 295
VAL C 297
 None
 1.23A 2qboA-3x1lC:
undetectable		 2qboA-3x1lC:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBO_A_CAMA442_0
(CYTOCHROME P450-CAM)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		5 / 10 PHE C  11
VAL C 318
VAL C 123
ILE C 295
VAL C 297
 None
 0.94A 2qboA-3x1lC:
undetectable		 2qboA-3x1lC:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHF_A_ACTA509_0
(CHORISMATE SYNTHASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		3 / 3 ARG A 658
GLN A 277
PRO A 278
 None
 0.95A 2qhfA-3x1lA:
undetectable		 2qhfA-3x1lA:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R2V_D_ACTD36_0
(GCN4 LEUCINE ZIPPER)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		3 / 3 SER H 149
TYR H 146
HIS H 145
 None
None
U  I  26 ( 3.5A)
 0.78A 2r2vD-3x1lH:
undetectable		 2r2vD-3x1lH:
7.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_B_SAMB602_0
(HYPOTHETICAL PROTEIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 GLY A 265
ALA A 304
VAL A 269
ASP A 262
VAL A 259
 None
 1.00A 2yvlB-3x1lA:
undetectable		 2yvlB-3x1lA:
18.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZBZ_A_VDXA501_1
(CYTOCHROME P450-SU1)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		6 / 11 THR H 248
LEU H 258
VAL H 291
SER H  33
ILE H 123
ALA H 245
 None
 1.32A 2zbzA-3x1lH:
undetectable		 2zbzA-3x1lH:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZTH_A_SAMA305_1
(CATECHOL
O-METHYLTRANSFERASE)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 SER C  15
GLU C 260
ASP C 288
 None
 0.83A 2zthA-3x1lC:
undetectable		 2zthA-3x1lC:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWM_A_SAMA301_1
(CATECHOL
O-METHYLTRANSFERASE)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 SER C  15
GLU C 260
ASP C 288
 None
 0.73A 3bwmA-3x1lC:
undetectable		 3bwmA-3x1lC:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWY_A_SAMA301_1
(COMT PROTEIN)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 SER C  15
GLU C 260
ASP C 288
 None
 0.77A 3bwyA-3x1lC:
undetectable		 3bwyA-3x1lC:
23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_B_CHDB200_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 5 PRO C 134
VAL C 135
THR C  40
GLY C  41
 None
 1.21A 3elzB-3x1lC:
undetectable		 3elzB-3x1lC:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM0_B_CHDB150_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 12 ILE H  35
VAL H 110
LEU H 113
ILE H 123
THR H 121
 None
None
C  I  28 ( 4.7A)
None
None
 1.28A 3em0B-3x1lH:
undetectable		 3em0B-3x1lH:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G2O_A_SAMA500_1
(PCZA361.24)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		3 / 3 ARG H 104
GLU H 259
ASP H  65
 None
 0.88A 3g2oA-3x1lH:
undetectable		 3g2oA-3x1lH:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GP0_A_NILA1_2
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 7 ARG C 344
VAL C 108
LEU C  50
ILE C 315
 None
 0.92A 3gp0A-3x1lC:
undetectable		 3gp0A-3x1lC:
24.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW4_A_TICA600_1
(CYTOCHROME P450 2B4)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 ILE H 162
SER H 223
ALA H 209
VAL H 224
GLY H 225
 None
 0.84A 3kw4A-3x1lH:
undetectable		 3kw4A-3x1lH:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_A_AICA375_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 GLY H 130
LEU H  36
ASN H  37
LEU H  71
LEU H  75
 None
 1.18A 3ndvA-3x1lH:
undetectable
3ndvB-3x1lH:
undetectable		 3ndvA-3x1lH:
21.50
3ndvB-3x1lH:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_B_AICB376_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 LEU H  71
LEU H  75
GLY H 130
LEU H  36
ASN H  37
 None
 1.19A 3ndvA-3x1lH:
undetectable
3ndvB-3x1lH:
undetectable		 3ndvA-3x1lH:
21.50
3ndvB-3x1lH:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_C_AICC375_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 GLY H 130
LEU H  36
ASN H  37
LEU H  71
LEU H  75
 None
 1.18A 3ndvC-3x1lH:
undetectable
3ndvD-3x1lH:
undetectable		 3ndvC-3x1lH:
21.50
3ndvD-3x1lH:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_D_AICD374_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 LEU H  71
LEU H  75
GLY H 130
LEU H  36
ASN H  37
 None
 1.20A 3ndvC-3x1lH:
undetectable
3ndvD-3x1lH:
undetectable		 3ndvC-3x1lH:
21.50
3ndvD-3x1lH:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NT1_A_NPSA5_1
(PROSTAGLANDIN-ENDOPE
ROXIDE SYNTHASE 2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 LEU A 375
LEU A 424
VAL A 306
ALA A 304
LEU A 303
 None
 1.09A 3nt1A-3x1lA:
1.6		 3nt1A-3x1lA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NT1_B_NPSB4_1
(PROSTAGLANDIN-ENDOPE
ROXIDE SYNTHASE 2)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 LEU A 375
LEU A 424
VAL A 306
ALA A 304
LEU A 303
 None
 1.07A 3nt1B-3x1lA:
1.5		 3nt1B-3x1lA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OCT_A_1N1A663_2
(TYROSINE-PROTEIN
KINASE BTK)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus;
Pyrococcus
furiosus) 		4 / 5 PHE F  15
ILE F 139
MET A 810
PHE F  13
 None
 1.41A 3octA-3x1lF:
undetectable		 3octA-3x1lF:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E7C_D_ACTD504_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 GLY C  24
SER C  23
TRP C  46
 U  I   9 ( 4.6A)
None
None
 0.55A 4e7cD-3x1lC:
undetectable		 4e7cD-3x1lC:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EYS_A_ACTA402_0
(MCCC FAMILY PROTEIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 6 SER A 236
ASP A 241
ARG A 485
GLU A 475
 None
 1.21A 4eysA-3x1lA:
undetectable		 4eysA-3x1lA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F4D_B_CHDB505_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus) 		5 / 12 LEU F 111
LEU F  98
LEU F  94
ILE F 131
THR F  54
 None
 1.06A 4f4dB-3x1lF:
undetectable		 4f4dB-3x1lF:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KQI_A_NIOA403_1
(NICOTINATE-NUCLEOTID
E--DIMETHYLBENZIMIDA
ZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 9 GLY A 856
PHE A 860
LEU A 857
SER A 761
ARG A 846
 None
 1.31A 4kqiA-3x1lA:
undetectable		 4kqiA-3x1lA:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB504_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		3 / 3 LEU A 242
ILE A 233
ARG A 731
 None
 0.71A 4mk4B-3x1lA:
undetectable		 4mk4B-3x1lA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWX_A_ZMRA513_2
(NEURAMINIDASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus) 		3 / 3 ARG F  10
TRP F  97
ILE F   6
 None
 1.09A 4mwxA-3x1lF:
undetectable		 4mwxA-3x1lF:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OR0_A_NPSA603_1
(SERUM ALBUMIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus) 		5 / 11 LEU F  98
ARG F  10
LEU F 137
LEU F 111
LEU F  51
 None
 1.31A 4or0A-3x1lF:
undetectable		 4or0A-3x1lF:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PWD_C_NVPC901_1
(HIV-1 REVERSE
TRANSCRIPTASE, P66
SUBUNIT)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 8 LEU A 326
VAL A 368
TYR A 365
LEU A 252
 None
 1.06A 4pwdC-3x1lA:
1.7		 4pwdC-3x1lA:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_J_CHDJ103_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 LEU H  32
LEU H  36
LEU H  71
GLU H 259
LEU H 289
 None
 0.78A 4wg0J-3x1lH:
undetectable
4wg0K-3x1lH:
undetectable
4wg0L-3x1lH:
undetectable		 4wg0J-3x1lH:
3.92
4wg0K-3x1lH:
3.92
4wg0L-3x1lH:
3.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_K_CHDK103_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 11 GLU H 259
LEU H 289
LEU H  71
LEU H  32
LEU H  36
 None
 1.18A 4wg0I-3x1lH:
undetectable
4wg0J-3x1lH:
undetectable
4wg0K-3x1lH:
undetectable		 4wg0I-3x1lH:
3.92
4wg0J-3x1lH:
3.92
4wg0K-3x1lH:
3.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XI3_C_29SC601_2
(ESTROGEN RECEPTOR)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 6 LEU A 274
GLU A 267
ILE A 224
PRO A 639
 None
 0.97A 4xi3C-3x1lA:
undetectable		 4xi3C-3x1lA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUD_A_SAMA303_1
(CATECHOL
O-METHYLTRANSFERASE)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 SER C  15
GLU C 260
ASP C 288
 None
 0.76A 4xudA-3x1lC:
undetectable		 4xudA-3x1lC:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1A_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 7 ILE A 226
LEU A 249
ARG A 321
LEU A 326
 None
 0.88A 5b1aA-3x1lA:
undetectable
5b1aJ-3x1lA:
undetectable		 5b1aA-3x1lA:
19.89
5b1aJ-3x1lA:
6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B3S_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 7 ILE A 226
LEU A 249
ARG A 321
LEU A 326
 None
 0.90A 5b3sA-3x1lA:
undetectable
5b3sJ-3x1lA:
undetectable		 5b3sA-3x1lA:
19.89
5b3sJ-3x1lA:
6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DQY_A_BEZA401_0
(THIOREDOXIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 8 ILE A 819
LYS A 828
VAL A 815
GLU A 832
 None
 1.20A 5dqyA-3x1lA:
undetectable		 5dqyA-3x1lA:
10.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FSA_A_X2NA590_2
(CYP51 VARIANT1)		 3x1l CMR4
CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus) 		3 / 3 PRO C 134
ILE F   6
SER C 287
 None
 0.73A 5fsaA-3x1lC:
undetectable		 5fsaA-3x1lC:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IGZ_A_SPRA404_2
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 9 LEU A 780
ILE A 864
ILE A 838
GLU A 814
GLU A 775
 None
 1.46A 5igzA-3x1lA:
undetectable		 5igzA-3x1lA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JW1_B_CELB602_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 6 VAL C  19
VAL C  53
ILE C 295
PHE C  11
 None
G  I   8 ( 4.3A)
None
None
 0.98A 5jw1B-3x1lC:
undetectable		 5jw1B-3x1lC:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA
TYPE-8,PROTEASOME
SUBUNIT BETA TYPE-5
PROTEASOME SUBUNIT
BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA
TYPE-6,PROTEASOME
SUBUNIT BETA
TYPE-1,PROTEASOME
SUBUNIT BETA TYPE-6)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 9 SER A 246
SER A 250
VAL A 295
ALA A 670
SER A 653
 None
 1.48A 5l5fK-3x1lA:
undetectable
5l5fL-3x1lA:
0.0		 5l5fK-3x1lA:
15.91
5l5fL-3x1lA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MWY_A_YNUA1101_0
(MINERALOCORTICOID
RECEPTOR)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 12 LEU A 676
ALA A 688
SER A 711
LEU A 710
LEU A 734
 None
 1.19A 5mwyA-3x1lA:
undetectable		 5mwyA-3x1lA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OG9_A_TESA503_1
(-)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 9 LEU A 303
LEU A 424
ILE A 314
MET A 253
LEU A 257
 None
 1.33A 5og9A-3x1lA:
1.2		 5og9A-3x1lA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR5
(Archaeoglobus
fulgidus) 		5 / 12 TYR F  35
LYS F 144
LEU F  94
ILE F  45
ALA F  42
 None
 1.18A 5v0vA-3x1lF:
undetectable		 5v0vA-3x1lF:
15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X23_A_LSNA502_1
(CYTOCHROME P450 2C9)		 3x1l CMR6
(Archaeoglobus
fulgidus) 		5 / 12 ALA H  56
PHE H  67
VAL H   5
LEU H  32
LEU H  71
 None
 1.46A 5x23A-3x1lH:
undetectable		 5x23A-3x1lH:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_B_CHDB401_0
(BILE SALT HYDROLASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 10 LEU A 747
ILE A 864
LEU A 861
PHE A 858
LEU A 842
 None
 1.23A 5y7pB-3x1lA:
undetectable		 5y7pB-3x1lA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_C_CHDC401_0
(BILE SALT HYDROLASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 8 TYR A 758
PHE A 860
ALA A 748
LEU A 762
 None
 0.88A 5y7pC-3x1lA:
undetectable		 5y7pC-3x1lA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_D_CHDD401_0
(BILE SALT HYDROLASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 10 LEU A 747
ILE A 864
LEU A 861
PHE A 858
LEU A 842
 None
 1.26A 5y7pD-3x1lA:
undetectable		 5y7pD-3x1lA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_E_CHDE401_0
(BILE SALT HYDROLASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 8 TYR A 758
PHE A 860
ALA A 748
LEU A 762
 None
 0.85A 5y7pE-3x1lA:
undetectable		 5y7pE-3x1lA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_H_CHDH401_0
(BILE SALT HYDROLASE)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		5 / 10 LEU A 747
ILE A 864
LEU A 861
PHE A 858
LEU A 842
 None
 1.22A 5y7pH-3x1lA:
undetectable		 5y7pH-3x1lA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCP_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 7 ILE A 226
LEU A 249
ARG A 321
LEU A 326
 None
 0.98A 5zcpA-3x1lA:
undetectable
5zcpJ-3x1lA:
undetectable		 5zcpA-3x1lA:
19.89
5zcpJ-3x1lA:
6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCQ_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
(Pyrococcus
furiosus) 		4 / 7 ILE A 226
LEU A 249
ARG A 321
LEU A 326
 None
 0.90A 5zcqA-3x1lA:
undetectable
5zcqJ-3x1lA:
undetectable		 5zcqA-3x1lA:
19.89
5zcqJ-3x1lA:
6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FGD_A_ACTA824_0
(GEPHYRIN)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		4 / 4 LEU C  63
ASP C 101
PRO C 102
ARG C  59
 None
None
None
G  I   8 ( 4.9A)
 1.18A 6fgdA-3x1lC:
undetectable		 6fgdA-3x1lC:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NCS_A_ACTA303_0
(N-ACETYLNEURAMINIC
ACID (SIALIC ACID)
SYNTHETASE)		 3x1l CMR4
(Archaeoglobus
fulgidus) 		3 / 3 ILE C 245
THR C 186
PRO C 148
 None
 0.62A 6ncsA-3x1lC:
undetectable		 6ncsA-3x1lC:
21.83